10.02.2018 Issue 421

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

PBMs: A Mechanism for Containing Costs
or a Contributor to Rising Drug Prices?

Monday, October 1

While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers have come under increased drug price scrutiny.

Survey Finds Wide Use, Experimentation with Blockchain

Rosenbloom: No More Exploitation of Seniors, Taxpayers by PBMs

Pro Pharma Announces New Medical Specialty Rebates Program

Packer Critical of Apple Watch’s Heart Monitoring Functions

Azar Touts Drop in Health Premiums, Administration

Study: Accelerated Adoption of Development Innovations Could Boost Pharma Sustainability

Drug Launch Pricing an Evolving Landscape

CVS Caremark’s Foray into Cost-Effectiveness Analysis Raises Questions About Future of Prescription Medicines in America


Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director Real World Evidence (RWE) and Epidemiology

Associate Director/ Director, Medical Affairs- HEOR

Watson Health - Outcomes Research Leader (HEOR)

Industry Spotlight


Conferences Webinars
9th Clinical Biomarkers and World CDx Boston
    October 2-5, Boston, Massachusetts

8th EPP Life Sciences Pricing Forum
    October 3-5, Montreux, Switzerland

2018 Hospital Observation Patient Management Summit
    October 4-5, Chicago, Illinois

InnoHEALTH 2018
    October 5-6, Gurugram, India

European Epidemiological Forum, 2018
   October 8, Zurich, Switzerland

Constrained Optimization Methods in Health Services Research — An Introduction
    October 2

ICER Reports’ Impact on US Drug Coverage Decisions: Passing Fad or Game Changer?
    October 9

Unlocking the Power of Pragmatic Clinical Trials: Learnings from Real-World Examples
   October 11

HIPAA and Business Associates - New Responsibilities and Obligations
    October 11


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: US Payer Perspectives

Health Care USA: A Cancer on the American Dream

The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment


 
Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL  Xcenda
        OM1Parexel   Jefferson   Dymaxium   Precision Xtract
          Pharmerit    eMax Health   SciformixEvidence Partners
          ICON    Truven